Amphiphilic Dendrimer Doping Enhanced pH‐Sensitivity of Liposomal Vesicle for Effective Co‐delivery toward Synergistic Ferroptosis–Apoptosis Therapy of Hepatocellular Carcinoma
Advanced Healthcare Materials · 2023
DOI: 10.1002/adhm.202202663 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2023. Verfasst von Yanhong Su und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Health Sciences, University of Macau, Taipa, Macau, 999078, P. R. China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Ferroptosis, Dendrimers, Liver Neoplasms. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Ferroptosis, characterized by the accumulation of reactive oxygen species and lipid peroxides, has emerged as an attractive strategy to reverse drug resistance. Of particular interest is the ferroptosis–apoptosis combination therapy for cancer treatment. Herein, a nanoplatform is reported for effective co‐delivery of the anticancer drug sorafenib (S) and the ferroptosis inducer hemin (H), toward synergistic ferroptosis–apoptosis therapy of advanced hepatocellular carcinoma (HCC) as a proof‐of‐concept study. Liposome is an excellent delivery system; however, it is not sufficiently responsive to the acidic tumor microenvironment (TME) for tumor‐targeted drug delivery. The pH‐sensitive vesicles are therefore developed (SH‐AD‐L) by incorporating amphiphilic dendrimers (AD) into liposomes for controlled and pH‐stimulated release of sorafenib and hemin in the acidic TME, thanks to the protonation of numerous amine functionalities in AD. Importantly, SH‐AD‐L not only blocked glutathione synthesis to disrupt the antioxidant system, but also increased intracellular Fe 2+ and ·OH concentrations to amplify oxidative stress, both of which contribute to enhanced ferroptosis. Remarkably, high levels of ·OH also augmented sorafenib‐mediated apoptosis in tumor cells. This study demonstrates the efficacy of ferroptosis–apoptosis combination therapy, as well as the promise of the AD‐doped TME‐responsive vesicles for drug delivery in combination therapy to treat advanced HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Health Sciences, University of Macau, Taipa, Macau, 999078, P. R. China.
- Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai People's Hospital (Zhuhai Hospital Affiliated with Jinan University), Zhuhai, Guangdong, 519000, P. R. China.
- MOE Frontiers Science Centre for Precision Oncology, University of Macau, Taipa, Macau, 999078, P. R. China.
- Aix Marseille Université, CNRS, Centre Interdisciplinaire de Nanoscience de Marseille (CINaM), UMR 7325, Equipe Labellisée Ligue Contre le Cancer, Marseille, 13288, France.
ORCID-Profile: Ligong Lu, Xuanjun Zhang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Su, Y., Zhang, Z., Lee, L. T. O., Peng, L., Lu, L., He, X., & Zhang, X. (2023). Amphiphilic Dendrimer Doping Enhanced pH‐Sensitivity of Liposomal Vesicle for Effective Co‐delivery toward Synergistic Ferroptosis–Apoptosis Therapy of Hepatocellular Carcinoma. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202202663
Vancouver
Su Y, Zhang Z, Lee LTO, Peng L, Lu L, He X, et al. Amphiphilic Dendrimer Doping Enhanced pH‐Sensitivity of Liposomal Vesicle for Effective Co‐delivery toward Synergistic Ferroptosis–Apoptosis Therapy of Hepatocellular Carcinoma. Advanced Healthcare Materials. 2023. doi:10.1002/adhm.202202663
BibTeX
@article{Su2023,
author = {Su, Yanhong and Zhang, Zhao and Lee, Leo Tsz On and Peng, Ling and Lu, Ligong and He, Xu and Zhang, Xuanjun},
title = {Amphiphilic Dendrimer Doping Enhanced pH‐Sensitivity of Liposomal Vesicle for Effective Co‐delivery toward Synergistic Ferroptosis–Apoptosis Therapy of Hepatocellular Carcinoma},
journal = {Advanced Healthcare Materials},
year = {2023},
doi = {10.1002/adhm.202202663}
}
EUVIMED